Última Hora: "Lei 'Uber' foi ?aprovada por 80% dos deputados?, recorda Uber Portugal - Jornal Económico" Wed, 19 Sep 2018 19:00:46 GMT    "Plataforma cívica e associações agendam protesto contra aeroporto no Montijo - Dinheiro Vivo" Wed, 19 Sep 2018 18:34:00 GMT    "Sonae coloca retalho alimentar em bolsa até ao fim do ano - Expresso" Wed, 19 Sep 2018 08:50:00 GMT    "Espanha suspende impostos sobre as elétricas para travar escalada dos preços - Observador" Wed, 19 Sep 2018 19:31:51 GMT    "Worten investe 7 milhões no novo negócio digital Marketplace - Jornal de Negócios - Portugal" Wed, 19 Sep 2018 16:23:00 GMT    "Bruxelas exige à Ryanair que mostre ?responsabilidade social? - TVI24" Wed, 19 Sep 2018 17:43:00 GMT   "" Wed, 19 Sep 2018 20:35:43 GMT    "Pilotos da Ryanair pedem nova liderança aos acionistas - Correio da Manhã" Wed, 19 Sep 2018 17:22:54 GMT    "Transferências imediatas. O seu ordenado vai passar a chegar à conta um dia mais cedo - Observador" Wed, 19 Sep 2018 15:08:42 GMT    "Governo desafia PSD para consensos nos investimentos, mas só ouve críticas - Expresso" Wed, 19 Sep 2018 18:24:00 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Queda de
--10.00 (+0.97%) SCHERING PLOUGH C - [Ticker: SGP]Gráfico SCHERING PLOUGH C  Notícias SCHERING PLOUGH C  Download de Históricos Metastock SCHERING PLOUGH C e Outros  Análise Técnica SCHERING PLOUGH C  
Última Trade368,000Range 52 Semanas[0,000 - 0,000]
Hora da Última Trade2018-09-14 - 00:00:00Price-Target 1 Ano0,000
Variação--10.00 (+0.97%)Capitalização Bolsista0
Bid / AskN/AEPS0,00
Abertura378,000PER0,00%
Máximo378,000Pagamento Dividendo
Mínimo368,000Data Ex-Dividendo
Fecho Anterior378,000Yield
Volume420Volume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de SCHERING PLOUGH C -  [Ticker: SGP]
Mudar para Gráfico de Análise Técnica Interactiva de SCHERING PLOUGH C

Últimos 10 Tópicos no Fórum sobre SCHERING PLOUGH C:
Não foram encontrados tópicos sobre SCHERING PLOUGH C [SGP], mas aconselha-se pesquisa no Fórum por tópicos relacionados com SCHERING PLOUGH C.

 Notícias sobre SCHERING PLOUGH C [SGP]:   (ordenadas por relevância)

Marketing magazine Australia

Making sense out of madness ? how this marketer is making it look ...
Marketing magazine Australia
The client list was vast, with more than 60 charities and pharmaceutical companies across the UK and Canada, including WWF, Oxfam and Schering-Plough. But she realised this wasn't the right path for her. ?I wasn't interested in making something appealing.


La Montagne

La nouvelle vie du Biopôle Clermont-Limagne à Riom grâce aux ...
La Montagne
C'est l'exemple d'une reconversion réussie. À Riom, dans le quartier de la Varenne, à deux pas de la rocade, un vaste site de 4 hectares, dont 1,2 hectares de bâtiments, s'offre une seconde vie grâce aux sciences du vivant, depuis 2013. À l'époque ...


Forbes Middle East

Pharma Billionaire Charged With Penny Stock Fraud
Forbes Middle East
Investigators allege an investor named Barry C. Honig served as the ringleader of the scheme. In each of three ... They sold that company, the developer of some of the first sustained release formulations, to Schering-Plough in 1986 for $836 million ...

e mais »

Newswise (press release)

Biotechnology Company Regeneron and Journalist and Filmmaker ...
Newswise (press release)
Former Grace Award winners include: Bill Anderson, CEO of Genentech, and philanthropist and New York City real estate developer Bruce Ratner (2017); Robert A. Bradway, chairman and CEO of Amgen (2016); Kenneth C. Frazier, chairman and CEO of ...


Interferon Biosimilar Sales Market Revenue Market Share Forecast ...
Newszak (blog)
Interferon Biosimilar Sales Market report shares premium data and relevant insights giving current state of Interferon Biosimilar Sales industry to make this research significant tool by segmenting on the basis of product and application. Interferon ...

e mais »

theperfectinvestor.com

Interferon Biosimilar Market Growth Forecast Analysis by ...
Zherald
Roche Biosidus Zydus Cadila Nanogen Amega Biotech Rhein Minapharm Biogenetics PROBIOMED 3sbio Amgen Bayer Schering Plough Merck and many more. For Market chain analysis, the report covers upstream raw materials, equipment, downstream client survey ...
Global Interferon Biosimilar Market Outlook 2018-PROBIOMED ...theperfectinvestor.com

todos os 3 artigos de notícias »

Anti-Viral Drugs 2018 Global Market Key Players - GlaxoSmithKline ...
Industry Today (press release)
Roche Abbott Gilead Johnson & Johnson Merck & Co Schering-Plough Cipla Bristol-Myers-Squibb AstraZeneca. Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3330661-global-anti-viral-drugs-industry-market-research-report.

e mais »

greenenergy24.com

Global Interferon Biosimilar Market Outlook, Size, Status, and ...
greenenergy24.com
QYResearch.us presents a new market intelligence report on title ?Global Interferon Biosimilar Market Insights and Forecast to 2025?. The Interferon Biosimilar market research report studies the Interferon Biosimilar industry extensively w.r.t company ...

e mais »

Global Interferon Biosimilar Market Report: Revenue Status, Cost ...
Newszak (blog)
Interferon Biosimilar market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyses the top manufacturers in global and major regions, and splits the Interferon ...

e mais »

HiTechReporter

Global Interferon Biosimilar Market 2018 ? Roche, Biosidus, Zydus ...
HiTechReporter
... Middle East & Africa- Saudi Arabia, Turkey, Rest of Middle East & Africa.' The major players covered in Global Interferon Biosimilar Market report- Roche, Biosidus, Zydus Cadila, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics, PROBIOMED, 3sbio ...

e mais »

Anti-Viral Drugs Market 2018- Global Industry Analysis, By Key ...
theperfectinvestor.com
Anti-Viral Drugs ? Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2023. Anti-Viral Drugs Market 2018. Wiseguyreports.Com Adds ?Anti-Viral Drugs ? Global Market Demand, Growth, Opportunities, ...


Interferon Biosimilar Market 2018-2025 by Economic/Political ...
Expert Herald (press release) (blog)
Interferon Biosimilar Market report provides complete evaluation for those who are looking for Business expand in various regions, manufacturers, New entrants in the industry, Professional organisation/solutions providers, Government bodies, financial ...

e mais »

Reuters

Keytruda sales power Merck to quarterly beat
Reuters
(Reuters) - Drugmaker Merck & Co (MRK.N) reported better-than-expected first-quarter earnings on Tuesday, helped by a more than 150 percent rise in sales of blockbuster cancer drug Keytruda.


The Economist

A pharmaceutical firm bets big on a cancer drug
The Economist
Merck's merger with another pharma firm, Schering-Plough, in 2009, had brought it an obscure new cancer drug. At first Merck's scientists were unimpressed and relegated the drug to a list of assets to be licensed out. There was widespread scepticism at ...


Merck, Schering-Plough set to complete merger
Reuters
NEW YORK (Reuters) - Merck & Co (MRK.N) and Schering-Plough Corp SGP.N said their $41.1 billion merger will be completed later on Tuesday, marking the close of the second huge deal in the pharmaceutical industry in recent weeks. Pfizer Inc (PFE.

Para mais notícias sobre SCHERING PLOUGH C clique aqui:
Notícias de SCHERING PLOUGH C

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters